LEADER 05129nam  2200673 a 450 
001 9910827242003321
005 20240516083245.0
010   $a1-283-14366-6
010   $a9786613143662
010   $a981-4271-27-6
035   $a(CKB)3360000000001313
035   $a(EBL)731182
035   $a(OCoLC)740444823
035   $a(SSID)ssj0000521221
035   $a(PQKBManifestationID)12179791
035   $a(PQKBTitleCode)TC0000521221
035   $a(PQKBWorkID)10517690
035   $a(PQKB)10488587
035   $a(MiAaPQ)EBC731182
035   $a(WSP)00007248
035   $a(Au-PeEL)EBL731182
035   $a(CaPaEBR)ebr10479966
035   $a(CaONFJC)MIL314366
035   $a(EXLCZ)993360000000001313
100   $a20100618d2010      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aBone marrow transplantation across major genetic barriers /$feditors, Yair Reisner, Massimo F. Martelli
205   $a1st ed.
210   $aHackensack, N.J. $cWorld Scientific$d2010
215   $a1 online resource (250 p.)
300   $aDescription based upon print version of record.
311   $a981-4271-26-8 
320   $aIncludes bibliographical references and index.
327   $aThe haploidentical option for high-risk haematological malignancies / Franco Aversa, Yair Reisner, and Massimo F. Martelli -- Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning / Wolfgang A. Bethge -- The challenge in hematopoietic stem cell transplantation : shortening the immunodeficiency period / Liliane Dal Cortivo ... [et al.] -- Hematopoietic stem cell transplantation across genetic barriers using a nonmyeloablative conditioning regimen -- / Liang-Piu Koh, David A. Rizzieri, and Nelson J. Chao -- Adoptive immunotherapy for prophylaxis and therapy of infectious complications after allogeneic hematopoietic stem cell transplantation / Markus Kapp, Hermann Einsele, and Go?tz Ulrich Grigoleit -- Alloreactive T cells for the treatment of leukemia / J.H. Frederik Falkenburg -- Alloanergization in haploidentical hematopoietic stem cell transplantation / Jeff K. Davies, Lee M. Nadler, and Eva C. Guinan -- The role of the thymus in hematopoietic stem cell transplantation / Werner Krenger and Georg A. Holla?nder -- A revolutionary BMT method / Susumu Ikehara -- Treatment of adenovirus infection after haploidentical stem cell transplantation in children / Tobias Feuchtinger, Rupert Handgretinger, and Peter Lang -- Mobilization of hematopoietic stem and progenitor cells / Kfir Lapid ... [et al.] -- Regulatory T cell therapy for immunomodulation after allogeneic hematopoietic cell transplantation / Robert Zeiser and Robert S. Negrin -- Immune reconstitution after haploidentical hematopoietic stem cell transplantation / Ami Shah ... [et al.] -- Human T cell differentiation : new techniques, old challenges / Jean Plum ... [et al.] -- Crossing HLA barriers by "megadose" stem cell transplants / Yair Reisner, Massimo F. Martelli, and Esther Bachar-Lustig -- Pathogen-induced immune regulation in transplantation / Luigina Romani -- Optimising adoptive T cell therapy following allogeneic hematopoietic stem cell transplantation / Sara Ghorashian ... [et al.] -- Hematopoietic cell transplantation for induction of transplantation tolerance : from animal models to clinical trials / Megan Sykes -- Unmanipulated HLA-mismatched/haploidentical blood and marrow hematopoietic stem cell transplantation / Xiao-Jun Huang -- Deploying natural killer cell allotherapy in the setting of HLA-haplotype-mismatched hematopoietic stem cell transplantation / Andrea Velardi ... [et al.].
330   $aThe importance of bone marrow transplantation for patients who do not have a matched sibling donor cannot be overestimated. This subject has always been in the public domain, accentuated by dramatic appeals, from time to time, to search for matched volunteer donors in the public at large. Unfortunately, the availability of such donors is limited, due to the remarkable genetic diversity of humans. Thus, although registries of such volunteers now include more than seven million individuals, we still face the problem of finding a matched donor for about 30 per cent of patients in need. To address
606   $aBone marrow$xTransplantation
606   $aHematopoietic stem cells
606   $aGraft versus host disease$xPrevention
606   $aGraft rejection$xPrevention
606   $aHuman immunogenetics
615  0$aBone marrow$xTransplantation.
615  0$aHematopoietic stem cells.
615  0$aGraft versus host disease$xPrevention.
615  0$aGraft rejection$xPrevention.
615  0$aHuman immunogenetics.
676   $a617.4/410592
701   $aReisner$b Yair$01662816
701   $aMartelli$b M. F$01662817
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910827242003321
996   $aBone marrow transplantation across major genetic barriers$94019741
997   $aUNINA